# Evaluation of Equivalent Minimum Alveolar Concentration (eMAC) During Propofol/Remifentanil Anesthesia

> **NCT05789992** · NA · COMPLETED · sponsor: **Zhang Haopeng** · enrollment: 62 (actual)

## Conditions studied

- General Anaesthesia

## Interventions

- **DRUG:** Propofol
- **DRUG:** Low Remifentanil
- **DRUG:** Heigh Remifentanil
- **PROCEDURE:** Intubation
- **PROCEDURE:** tetanic electrical stimulation

## Key facts

- **NCT ID:** NCT05789992
- **Lead sponsor:** Zhang Haopeng
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-04-03
- **Primary completion:** 2023-04-29
- **Final completion:** 2023-04-29
- **Target enrollment:** 62 (ACTUAL)
- **Last updated:** 2023-06-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05789992

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05789992, "Evaluation of Equivalent Minimum Alveolar Concentration (eMAC) During Propofol/Remifentanil Anesthesia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05789992. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*